Effects of glucagon-like peptide-1 agonist (GLP-1 agonist) and bariatric surgery on fertility-sparing management of endometrial cancer and oncofertility outcomes: experience from singapore’s oncofertility clinic

In: International Journal of Gynecological Cancer · 2026 · vol. 36(2) , pp. 103595 · doi:10.1016/j.ijgc.2025.103595 · W7129239293
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study investigated the impact of GLP-1 agonists and bariatric surgery on fertility-sparing endometrial cancer management and oncofertility outcomes at Singapore's oncofertility clinic.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-13T18:23:01.997123+00:00
License: CC0 · commercial use OK